The many faces of Artemis-deficient combined immunodeficiency — Two patients with DCLRE1C mutations and a systematic literature review of genotype–phenotype correlation

Abstract Defective V(D)J recombination and DNA double-strand break (DSB) repair severely impair the development of T-lymphocytes and B-lymphocytes. Most patients manifest a severe combined immunodeficiency during infancy. We report 2 siblings with combined immunodeficiency (CID) and immunodysregulat...

Full description

Saved in:
Bibliographic Details
Published inClinical immunology (Orlando, Fla.) Vol. 149; no. 3; pp. 464 - 474
Main Authors Lee, Pamela P, Woodbine, Lisa, Gilmour, Kimberly C, Bibi, Shahnaz, Cale, Catherine M, Amrolia, Persis J, Veys, Paul A, Davies, E. Graham, Jeggo, Penny A, Jones, Alison
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Defective V(D)J recombination and DNA double-strand break (DSB) repair severely impair the development of T-lymphocytes and B-lymphocytes. Most patients manifest a severe combined immunodeficiency during infancy. We report 2 siblings with combined immunodeficiency (CID) and immunodysregulation caused by compound heterozygous Artemis mutations, including an exon 1–3 deletion generating a null allele, and a missense change (p.T71P). Skin fibroblasts demonstrated normal DSB repair by gamma-H2AX analysis, supporting the predicted hypomorphic nature of the p.T71P allele. In addition to these two patients, 12 patients with Artemis-deficient CID were previously reported. All had significant morbidities including recurrent infections, autoimmunity, EBV-associated lymphoma, and carcinoma despite having hypomorphic mutants with residual Artemis expression, V(D)J recombination or DSB repair capacity. Nine patients underwent stem cell transplant and six survived, while four patients who did not receive transplant died. The progressive nature of immunodeficiency and genomic instability accounts for poor survival, and early HSCT should be considered.
Bibliography:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-6
ObjectType-Review-2
ObjectType-Case Study-4
ObjectType-Undefined-1
ObjectType-Report-3
ObjectType-Article-5
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1521-6616
1521-7035
DOI:10.1016/j.clim.2013.08.006